(Total Views: 462)
Posted On: 12/16/2019 7:47:41 AM
Post# of 155160
For those that read this board and think we're all crazy to abuse ourselves over a 30 cent stock. Here's something that will make you roll your eyes.
ArQule has a cancer therapy drug in Phase 1. The results partially worked in 10 patients.
And Merck decides to drop 2.7 billion dollars on them.
I think CYDY is going to be just fine.
(here is ARQL results)
https://seekingalpha.com/news/3515381-arqule-...on-arq-531
(Merck purchase)
https://seekingalpha.com/news/3524680-arqule-...-merck-bid
ArQule has a cancer therapy drug in Phase 1. The results partially worked in 10 patients.
And Merck decides to drop 2.7 billion dollars on them.
I think CYDY is going to be just fine.
(here is ARQL results)
https://seekingalpha.com/news/3515381-arqule-...on-arq-531
(Merck purchase)
https://seekingalpha.com/news/3524680-arqule-...-merck-bid
(3)
(0)
